Orchard Therapeutics Income Statement

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2020	FY 2019	FY 2018	2019 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	2019 - 2020
Revenue	1,060,806	904,149	782,309	658,743	539,107	467,844	Upgrade
Revenue Growth (YoY)	35.60%	15.57%	18.76%	22.19%	15.23%	3.37%	Upgrade
Cost of Revenue	752,801	643,190	648,408	570,255	446,520	389,419	Upgrade
Gross Profit	308,005	260,959	133,901	88,487	92,587	78,425	Upgrade
Selling, General & Admin	104,762	88,571	68,660	61,090	57,272	56,948	Upgrade
Operating Expenses	104,762	88,571	68,660	61,090	57,272	56,948	Upgrade
Operating Income	203,243	172,388	65,241	27,398	35,314	21,477	Upgrade
Interest Expense	-16,334	-16,402	-22,402	-10,054	-17,751	-16,060	Upgrade
Interest & Investment Income	7,453	7,453	10,750	9,827	9,217	4,490	Upgrade
Earnings From Equity Investments	30,088	19,314	9,351	81.57	-	-	Upgrade
Currency Exchange Gain (Loss)	6,801	6,801	-4,544	-	-	-	Upgrade
Other Non Operating Income (Expenses)	-119.33	-1,384	-85.07	-3,767	-4,703	-4,089	Upgrade
EBT Excluding Unusual Items	231,132	188,171	58,311	23,486	22,078	5,818	Upgrade
Gain (Loss) on Sale of Assets	158.96	158.96	7.07	-	-	-	Upgrade
Other Unusual Items	19.29	19.29	-	-	-	-	Upgrade
Pretax Income	231,310	188,349	58,318	23,486	22,078	5,818	Upgrade
Income Tax Expense	30,223	26,808	6,235	3,478	6,555	4,738	Upgrade
Earnings From Continuing Operations	201,087	161,541	52,083	20,008	15,523	1,080	Upgrade
Minority Interest in Earnings	-46.59	-34.06	222.89	269.72	8,361	6,296	Upgrade
Net Income	201,040	161,507	52,306	20,278	23,884	7,376	Upgrade
Preferred Dividends & Other Adjustments	556.7	556.7	2,099	-	-	-	Upgrade
Net Income to Common	200,484	160,950	50,207	20,278	23,884	7,376	Upgrade
Net Income Growth	284.36%	208.77%	157.95%	-15.10%	223.82%	-78.35%	Upgrade
Shares Outstanding (Basic)	17	17	17	17	17	17	Upgrade
Shares Outstanding (Diluted)	17	17	17	17	17	17	Upgrade
Shares Change (YoY)	-0.46%	-	-1.98%	-0.15%	2.11%	-	Upgrade
EPS (Basic)	11967.98	9563.28	2983.18	1181.00	1389.00	438.00	Upgrade
EPS (Diluted)	11967.70	9563.00	2983.00	1181.00	1389.00	438.00	Upgrade
EPS Growth	301.20%	220.58%	152.58%	-14.97%	217.12%	-	Upgrade
Free Cash Flow	110,657	163,362	49,761	-6,150	31,904	8,235	Upgrade
Free Cash Flow Per Share	6605.74	9706.60	2956.67	-358.19	1855.39	489.03	Upgrade
Dividend Per Share	-	-	-	1000.000	-	-	Upgrade
Gross Margin	29.04%	28.86%	17.12%	13.43%	17.17%	16.76%	Upgrade
Operating Margin	19.16%	19.07%	8.34%	4.16%	6.55%	4.59%	Upgrade
Profit Margin	18.90%	17.80%	6.42%	3.08%	4.43%	1.58%	Upgrade
Free Cash Flow Margin	10.43%	18.07%	6.36%	-0.93%	5.92%	1.76%	Upgrade
EBITDA	208,592	177,346	70,120	31,819	40,406	32,680	Upgrade
EBITDA Margin	19.66%	19.61%	8.96%	4.83%	7.50%	6.98%	Upgrade
D&A For EBITDA	5,349	4,958	4,880	4,421	5,092	11,203	Upgrade
EBIT	203,243	172,388	65,241	27,398	35,314	21,477	Upgrade
EBIT Margin	19.16%	19.07%	8.34%	4.16%	6.55%	4.59%	Upgrade
Effective Tax Rate	13.07%	14.23%	10.69%	14.81%	29.69%	81.44%	Upgrade
Revenue as Reported	1,060,806	904,149	782,309	658,743	539,107	467,844	Upgrade

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.